Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Adair

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
DNA Repair|May 27, 2005
Role of high mobility group (HMG) chromatin proteins in DNA repairRaymond Reeves, Jennifer E Adair
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Outside the box--novel therapeutic strategies for glioblastomaMaciej M Mrugala, Jennifer E Adair, Hans-Peter Kiem
Hematology/Oncology Clinics of North America|September 13, 2017
Hematopoietic Stem Cell Approaches to CancerJennifer E Adair, Sara P Kubek, Hans-Peter Kiem
DNA Repair|June 2, 2007
Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteinsScott C Maloney, Jennifer E Adair, Michael J Smerdon, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 27, 2014
High-throughput genomic mapping of vector integration sites in gene therapy studiesBrian C Beard, Jennifer E Adair, Grant D Trobridge, et al.
The Journal of Biological Chemistry|July 22, 2005
Inhibition of nucleotide excision repair by high mobility group protein HMGA1Jennifer E Adair, Youngho Kwon, Gregory A Dement, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
CRISPR Gene Editing of Hematopoietic Stem and Progenitor CellsReza Shahbazi, Patricia Lipson, Karthikeya S V Gottimukkala, et al.
JCI Insight|July 13, 2018
HIV infection results in clonal expansions containing integrations within pathogenesis-related biological pathwaysKevin G Haworth, Lauren E Schefter, Zachary K Norgaard, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2017
In Vivo Murine-Matured Human CD3<sup>+</sup> Cells as a Preclinical Model for T Cell-Based ImmunotherapiesKevin G Haworth, Christina Ironside, Zachary K Norgaard, et al.
Cancer Research|July 10, 2007
High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group AJennifer E Adair, Scott C Maloney, Gregory A Dement, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
DNA Repair|May 27, 2005
Role of high mobility group (HMG) chromatin proteins in DNA repairRaymond Reeves, Jennifer E Adair
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Outside the box--novel therapeutic strategies for glioblastomaMaciej M Mrugala, Jennifer E Adair, Hans-Peter Kiem
Hematology/Oncology Clinics of North America|September 13, 2017
Hematopoietic Stem Cell Approaches to CancerJennifer E Adair, Sara P Kubek, Hans-Peter Kiem
DNA Repair|June 2, 2007
Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteinsScott C Maloney, Jennifer E Adair, Michael J Smerdon, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 27, 2014
High-throughput genomic mapping of vector integration sites in gene therapy studiesBrian C Beard, Jennifer E Adair, Grant D Trobridge, et al.
The Journal of Biological Chemistry|July 22, 2005
Inhibition of nucleotide excision repair by high mobility group protein HMGA1Jennifer E Adair, Youngho Kwon, Gregory A Dement, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
CRISPR Gene Editing of Hematopoietic Stem and Progenitor CellsReza Shahbazi, Patricia Lipson, Karthikeya S V Gottimukkala, et al.
JCI Insight|July 13, 2018
HIV infection results in clonal expansions containing integrations within pathogenesis-related biological pathwaysKevin G Haworth, Lauren E Schefter, Zachary K Norgaard, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2017
In Vivo Murine-Matured Human CD3<sup>+</sup> Cells as a Preclinical Model for T Cell-Based ImmunotherapiesKevin G Haworth, Christina Ironside, Zachary K Norgaard, et al.
Cancer Research|July 10, 2007
High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group AJennifer E Adair, Scott C Maloney, Gregory A Dement, et al.
Pageof 6